Applicant, as named in the Orange Book

On Target Labs

Next listed expiry: Cytalux on 29 Nov 2035. 1 products with live protection, 0 without.

Products with listed protection

Drug	Ingredient	Earliest generic entry	Basis
Cytalux NDA 214907 pafolacianine sodium	pafolacianine sodium	29 Nov 2035 patent	patent

Cytalux · Exclusivity expires within 90 days NCEExclusivity expires 29 Nov 2026Detected 24 Oct 2026